117 related articles for article (PubMed ID: 23288242)
21. Anxious versus non-anxious depression: difference in treatment outcome.
Domschke K; Deckert J; Arolt V; Baune BT
J Psychopharmacol; 2010 Apr; 24(4):621-2. PubMed ID: 18838496
[No Abstract] [Full Text] [Related]
22. [The neurotrophic hypothesis of depression].
Bus BA; Molendijk ML
Tijdschr Psychiatr; 2016; 58(3):215-22. PubMed ID: 26979853
[TBL] [Abstract][Full Text] [Related]
23. Agomelatine Increases BDNF Serum Levels in Depressed Patients in Correlation with the Improvement of Depressive Symptoms.
Martinotti G; Pettorruso M; De Berardis D; Varasano PA; Lucidi Pressanti G; De Remigis V; Valchera A; Ricci V; Di Nicola M; Janiri L; Biggio G; Di Giannantonio M
Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26775293
[TBL] [Abstract][Full Text] [Related]
24. Decreased levels of brain-derived neurotrophic factor in the remitted state of unipolar depressive disorder.
Hasselbalch BJ; Knorr U; Bennike B; Hasselbalch SG; Søndergaard MH; Vedel Kessing L
Acta Psychiatr Scand; 2012 Sep; 126(3):157-64. PubMed ID: 22292883
[TBL] [Abstract][Full Text] [Related]
25. Electroconvulsive therapy exerts mainly acute molecular changes in serum of major depressive disorder patients.
Stelzhammer V; Guest PC; Rothermundt M; Sondermann C; Michael N; Schwarz E; Rahmoune H; Bahn S
Eur Neuropsychopharmacol; 2013 Oct; 23(10):1199-207. PubMed ID: 23183131
[TBL] [Abstract][Full Text] [Related]
26. Increased plasma levels of competing amino acids, rather than lowered plasma tryptophan levels, are associated with a non-response to treatment in major depression.
Ormstad H; Dahl J; Verkerk R; Andreassen OA; Maes M
Eur Neuropsychopharmacol; 2016 Aug; 26(8):1286-96. PubMed ID: 27237997
[TBL] [Abstract][Full Text] [Related]
27. Early response and remission as predictors of a good outcome of a major depressive episode at 12-month follow-up: a prospective, longitudinal, observational study.
Ciudad A; Álvarez E; Roca M; Baca E; Caballero L; García de Polavieja P; Casillas M; Valladares A; Gilaberte I
J Clin Psychiatry; 2012 Feb; 73(2):185-91. PubMed ID: 22053897
[TBL] [Abstract][Full Text] [Related]
28. Chronic Supplementation of Curcumin Enhances the Efficacy of Antidepressants in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Pilot Study.
Yu JJ; Pei LB; Zhang Y; Wen ZY; Yang JL
J Clin Psychopharmacol; 2015 Aug; 35(4):406-10. PubMed ID: 26066335
[TBL] [Abstract][Full Text] [Related]
29. Improved Alertness Is Associated with Early Increase in Serum Brain-Derived Neurotrophic Factor and Antidepressant Treatment Outcome in Major Depression.
Mikoteit T; Hemmeter U; Eckert A; Brand S; Bischof R; Delini-Stula A; Holsboer-Trachsler E; Beck J
Neuropsychobiology; 2015; 72(1):16-28. PubMed ID: 26337518
[TBL] [Abstract][Full Text] [Related]
30. Plasma brain-derived neurotrophic factor levels predict the clinical outcome of depression treatment in a naturalistic study.
Kurita M; Nishino S; Kato M; Numata Y; Sato T
PLoS One; 2012; 7(6):e39212. PubMed ID: 22761741
[TBL] [Abstract][Full Text] [Related]
31. Brain derived neurotrophic factor (BDNF) levels in depressed women treated with open-label escitalopram.
Ladea M; Bran M
Psychiatr Danub; 2013 Jun; 25(2):128-32. PubMed ID: 23793276
[TBL] [Abstract][Full Text] [Related]
32. Adjunctive N-acetylcysteine in depression: exploration of interleukin-6, C-reactive protein and brain-derived neurotrophic factor.
Hasebe K; Gray L; Bortolasci C; Panizzutti B; Mohebbi M; Kidnapillai S; Spolding B; Walder K; Berk M; Malhi G; Dodd S; Dean OM
Acta Neuropsychiatr; 2017 Dec; 29(6):337-346. PubMed ID: 28318471
[TBL] [Abstract][Full Text] [Related]
33. [Mechanisms of action of antidepressive drugs: new approaches].
David DJ
Encephale; 2012 Dec; 38 Suppl 2():S45-8. PubMed ID: 23279957
[No Abstract] [Full Text] [Related]
34. Identifying patients with therapy-resistant depression by using factor analysis.
Andreasson K; Liest V; Lunde M; Martiny K; Unden M; Dissing S; Bech P
Pharmacopsychiatry; 2010 Nov; 43(7):252-6. PubMed ID: 20821367
[TBL] [Abstract][Full Text] [Related]
35. Sequenced Treatment Alternatives to Relieve Depression (STAR*D): lessons learned.
Zisook S; Ganadjian K; Moutier C; Prather R; Rao S
J Clin Psychiatry; 2008 Jul; 69(7):1184-5. PubMed ID: 18687018
[No Abstract] [Full Text] [Related]
36. Efficacy of adjunctive aripiprazole in patients with major depressive disorder who showed minimal response to initial antidepressant therapy.
Nelson JC; Thase ME; Bellocchio EE; Rollin LM; Eudicone JM; McQuade RD; Marcus RN; Berman RM; Baker RA
Int Clin Psychopharmacol; 2012 May; 27(3):125-33. PubMed ID: 22466058
[TBL] [Abstract][Full Text] [Related]
37. Investigation of serum levels of sortilin in response to antidepressant treatment.
Buttenschøn HN; Nielsen M; Glerup S; Mors O
Acta Neuropsychiatr; 2018 Apr; 30(2):111-116. PubMed ID: 28478778
[TBL] [Abstract][Full Text] [Related]
38. Long-term naturalistic follow-up of lithium augmentation: relevance to bipolarity.
Inoue T; Abekawa T; Nakagawa S; Suzuki K; Tanaka T; Kitaichi Y; Boku S; Nakato Y; Toda H; Koyama T
J Affect Disord; 2011 Mar; 129(1-3):64-7. PubMed ID: 20837361
[TBL] [Abstract][Full Text] [Related]
39. BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine.
Ninan PT; Shelton RC; Bao W; Guico-Pabia CJ
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():86-91. PubMed ID: 24096053
[TBL] [Abstract][Full Text] [Related]
40. Effect of Mirtazapine Treatment on Serum Levels of Brain-Derived Neurotrophic Factor and Tumor Necrosis Factor-α in Patients of Major Depressive Disorder with Severe Depression.
Gupta R; Gupta K; Tripathi AK; Bhatia MS; Gupta LK
Pharmacology; 2016; 97(3-4):184-8. PubMed ID: 26854819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
